🔗 Visit the ClinicalTrials.gov page for NCT00107536
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. | Oncotarget | 2012 | 1.55 |
| 2 | Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. | World J Gastroenterol | 2008 | 1.31 |
| 3 | HER2/neu may not be an interesting target in biliary cancers: results of an early phase II study with lapatinib. | Oncology | 2012 | 0.88 |
| 4 | Targeted therapies in the treatment of advanced hepatocellular carcinoma. | Clin Med Insights Oncol | 2013 | 0.83 |
| 5 | Targeted medical therapy of biliary tract cancer: recent advances and future perspectives. | World J Gastroenterol | 2008 | 0.77 |